US Drug Recall Register

FDA Drug Recalls

436 recalls, newest first

Class II · Moderate risk Completed

Ranitidine Tablets 75 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 63868-482-30 D-0175-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 30142-131-30 D-0174-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 69842-871-30 D-0173-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 30142-505-34 D-0172-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 49035-404-61 D-0171-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 0363-0010-34 D-0170-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. D-0169-2020
Class II · Moderate risk Completed

Dr. Reddy's: Ranitidine Capsules 150 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 55111-129-60 D-0168-2020
Class II · Moderate risk Completed

Clear Eyes Redness Relief

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. D-0490-2020
Class II · Moderate risk Completed

Clear Eyes Redness Relief

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. D-0489-2020
Class II · Moderate risk Completed

Clear Eyes Redness Relief

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. D-0487-2020
Class II · Moderate risk Completed

FreshKote Lubricant Eye Drops

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. NDC 15821-101-15 D-0483-2020